Abstract
Figure S8. RGS5+MYL9+ CAFs protect against EGFR-TKI-induced mitochondrial dysfunction in vivo. (A) Flow cytometry analysis assesses total mitochondrial mass, damaged mitochondria levels in tumor cells and CAFs isolated from xenograft mice in Figure 2J. (B) Flow cytometry analysis assesses MitoSOX levels in tumor cells and CAFs isolated from xenograft mice in Figure 2J. Error bars represent mean ± SD, with significance indicated as ns not significant, *P <0.05, **P <0.01, ***P <0.001 according to independent sample t-tests.